|
TMEM192 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.07667216756136E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.86219986284686E-11 |
| Normal-vs-Stage2 |
6.21979999999578E-05 |
| Normal-vs-Stage3 |
1.92773999999618E-05 |
| Normal-vs-Stage4 |
2.36619999999244E-05 |
| Stage1-vs-Stage2 |
3.274600E-01 |
| Stage1-vs-Stage3 |
4.878800E-01 |
| Stage1-vs-Stage4 |
7.129400E-01 |
| Stage2-vs-Stage3 |
7.660800E-01 |
| Stage2-vs-Stage4 |
2.550400E-01 |
| Stage3-vs-Stage4 |
4.538000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64768199084619E-12 |
| Normal-vs-AfricanAmerican |
2.36820000054649E-07 |
| Normal-vs-Asian |
1.783850E-01 |
| Caucasian-vs-AfricanAmerican |
7.957200E-01 |
| Caucasian-vs-Asian |
8.140400E-01 |
| AfricanAmerican-vs-Asian |
6.856400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
2.20609999999066E-05 |
| Male-vs-Female |
1.276950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.11519999999888E-05 |
| Normal-vs-Extreme_Weight |
2.76950018474054E-10 |
| Normal-vs-Obese |
8.38699998340076E-09 |
| Normal-vs-Extreme_Obese |
3.206900E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.943190E-01 |
| Normal_Weight-vs-Obese |
6.426200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.868800E-01 |
| Extreme_Weight-vs-Obese |
8.075800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.319800E-01 |
| Obese-vs-Extreme_Obese |
7.735000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.79399999997465E-06 |
| Normal-vs-Age(41-60Yrs) |
1.05639996750284E-09 |
| Normal-vs-Age(61-80Yrs) |
3.09219316818599E-12 |
| Normal-vs-Age(81-100Yrs) |
3.228900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.298600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.214000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.272600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.091600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.925200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.636000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.36800004657545E-09 |
| Normal-VS-Type2 PRCC |
8.35890000000505E-05 |
| Normal-VS-KIRP CIMP |
8.35530000000695E-05 |
| Normal-VS-Unclassified PRCC |
2.127900000648E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.516130E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.953200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.413200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.205360E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.004180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.762200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.58990001351145E-09 |
| Normal-vs-N1 |
2.49129999999598E-05 |
| Normal-vs-N2 |
8.750400E-04 |
| N0-vs-N1 |
5.874000E-01 |
| N0-vs-N2 |
3.493200E-01 |
| N1-vs-N2 |
2.809800E-01 |
|
|
